Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir and Lamivudine for Entecavir-Resistant Chronic Hepatitis B
NCT01546116Phase 4Completed
- Sponsor
- Korea University
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of adefovir dipivoxil, lamivudine in Chronic Hepatitis B (CHB), sponsored by Korea University. Started Feb 2010; status: completed.
02
Drugs
adefovir dipivoxillamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01546116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01546116.